NCT01479231View on ClinicalTrials.gov

Predictors of Proton Pump Inhibitor (PPI) Response in Eosinophilic Esophagitis

PHASE1/PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

March 31, 2012

Primary Completion Date

March 31, 2012

Study Completion Date

March 31, 2012

Conditions
Gastroesophageal Reflux DiseaseEosinophilic EsophagitisDysphagia
Interventions
DRUG

dexlansoprazole

Dexlansoprazole 60 mg daily for 6 weeks

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER